Trials / Conditions / ALK-Positive Large B-Cell Lymphoma
ALK-Positive Large B-Cell Lymphoma
3 registered clinical trials studyying ALK-Positive Large B-Cell Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of SGR-1505 in Mature B-Cell Neoplasms NCT05544019 | Schrödinger, Inc. | Phase 1 |
| Recruiting | Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Agg NCT04231877 | University of Washington | Phase 1 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |